Last reviewed · How we verify

NCT03276507: MUSE

Multisystem Shortness of Breath Evaluation Study

Status unknown Last updated 9 November 2017
What this trial tests

trial testing Pulmonary function studies in Dyspnea in 60 participants. Status unknown.

Timeline
1 November 2016
Primary endpoint
1 December 2017
1 June 2018

Quick facts

Lead sponsorInstituto de Investigación Sanitaria de la Fundación Jiménez Díaz
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment60
Start date1 November 2016
Primary completion1 December 2017
Estimated completion1 June 2018
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz — full company profile →

Who can join

Adults 18 to 90, any sex, with Dyspnea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The MUSE study is a prospective observational cohort study of patients referred to pulmonary and/or cardiology specialty clinic for evaluation of shortness of breath or dyspnea. Patients will undergo all pertinent testing and will be required to fill out a number of epidemiologic and quality of life related questionnaires. Follow up will continue for at least one year.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Dyspnea

Currently open trials in the same condition.

Other Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03276507.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing